Literature DB >> 7030018

[Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].

Y Kitazawa, I Azuma, M Takase, S Komemushi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7030018

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN： 0029-0203


× No keyword cloud information.
  5 in total

1.  The 12-hour control of intraocular pressure on carteolol 2% twice daily.

Authors:  G R Duff; R G Newcombe
Journal:  Br J Ophthalmol       Date:  1988-12       Impact factor: 4.638

2.  Ocular hypotensive efficacy and safety of once daily carteolol alginate.

Authors:  P Demailly; C Allaire; C Trinquand
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 3.  Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

4.  A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.

Authors:  G R Duff; P A Graham
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

5.  A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.

Authors:  W C Stewart; M B Shields; R C Allen; R A Lewis; J S Cohen; H D Hoskins; J N Hetherington; R L Bahr; J E Noblin; J T Delehanty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.